Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
基本信息
- 批准号:7132766
- 负责人:
- 金额:$ 29.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:anthrax toxinantigen antibody reactionchemical modelscomputational biologycomputer program /softwarecomputer simulationcomputer system design /evaluationepidermal growth factorgrowth factor receptorsmethod developmentmolecular dynamicsmonoclonal antibodyprotein foldingprotein protein interactionprotein structure functiontherapy design /development
项目摘要
DESCRIPTION (provided by applicant): Therapeutic antibodies constitute a major class of current drugs under development because they can bind with high affinity and specificity to particular targets in the body or on an infectious agent. The structure of a therapeutic antibody bound to its antigen can be of value to reveal the structural origin of the mechanism of the drug's action and possibly indications of the mechanism of the antigen itself in a disease process. Also, the structure can be exploited for further protein engineering such as increasing binding affinity. We propose to develop tools to predict the structure of antibody-antigen complexes starting from the sequence of the antibody and an unbound structure of the antigen. We will improve and tailor docking scoring functions, develop homology models for docking, and develop flexible loop algorithms for docking to account for uncertainties in a homology antibody structure. Antibodies make an ideal test system for homology docking and flexible loop docking because the IgG fold is well-defined; when these techniques are developed, they will be of broad impact for the docking field in general. Finally, we will apply these techniques to two model systems for which the antibody-antigen complex structure is unknown. Monoclonal antibody 806 binds to the epidermal growth factor receptor and has been shown to be an effective therapy against several types of tumors. The 14B7 family of antibodies binds the anthrax toxin and prevents its cytotoxic effects. Both complex structures are currently unknown. We will predict structures and collaborate to validate the predictions experimentally. This research is relevant to public health because it will provide general computational tools to discover the structural mechanism of new protein drugs. In addition, this research will determine the structure for a novel cancer drug bound to its target and a novel antidote bound to the anthrax toxin, revealing the structural basis of the therapies and providing a foundation to tailor the drugs to increase their effectiveness.
描述(由申请人提供):治疗性抗体构成了目前正在开发的主要一类药物,因为它们可以以高亲和力和特异性结合体内或感染原上的特定靶点。与其抗原结合的治疗性抗体的结构对于揭示药物作用机制的结构起源以及疾病过程中抗原本身机制的可能指示具有价值。此外,该结构可以用于进一步的蛋白质工程,如增加结合亲和力。我们建议开发工具,从抗体序列和抗原的未结合结构开始预测抗体-抗原复合物的结构。我们将改进和定制对接评分函数,开发对接的同源模型,并开发灵活的环算法对接,以考虑同源抗体结构的不确定性。抗体是同源对接和柔性环对接的理想测试系统,因为IgG折叠是明确定义的;当这些技术被开发出来时,它们将对一般的对接领域产生广泛的影响。最后,我们将这些技术应用到两个模型系统的抗体-抗原复合物的结构是未知的。单克隆抗体806与表皮生长因子受体结合,已被证明是针对几种类型肿瘤的有效疗法。14 B7抗体家族与炭疽毒素结合并阻止其细胞毒性作用。这两种复杂的结构目前尚不清楚。我们将预测结构,并合作通过实验验证预测。这项研究与公共卫生有关,因为它将为发现新蛋白质药物的结构机制提供通用计算工具。此外,这项研究还将确定一种与其靶点结合的新型抗癌药物的结构和一种与炭疽毒素结合的新型解毒剂的结构,揭示这些疗法的结构基础,并为定制药物以提高其有效性提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY J GRAY其他文献
JEFFREY J GRAY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY J GRAY', 18)}}的其他基金
Prediction of the Structures of Protein Complexes
蛋白质复合物结构的预测
- 批准号:
10206954 - 财政年份:2021
- 资助金额:
$ 29.39万 - 项目类别:
Prediction of the Structures of Protein Complexes
蛋白质复合物结构的预测
- 批准号:
10407529 - 财政年份:2021
- 资助金额:
$ 29.39万 - 项目类别:
Prediction of the Structures of Protein Complexes
蛋白质复合物结构的预测
- 批准号:
10693822 - 财政年份:2021
- 资助金额:
$ 29.39万 - 项目类别:
Glycomutagenesis Tools for Structure-Based Prediction and Design of Glycosyl Transfer
用于基于结构的糖基转移预测和设计的糖突变工具
- 批准号:
9897664 - 财政年份:2018
- 资助金额:
$ 29.39万 - 项目类别:
Prediction of Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
8731999 - 财政年份:2013
- 资助金额:
$ 29.39万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
7487309 - 财政年份:2006
- 资助金额:
$ 29.39万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
8546392 - 财政年份:2006
- 资助金额:
$ 29.39万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
7680247 - 财政年份:2006
- 资助金额:
$ 29.39万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体及其抗原结构的预测
- 批准号:
9923648 - 财政年份:2006
- 资助金额:
$ 29.39万 - 项目类别:
Prediction of the Structure of Therapeutic Antibodies with their Antigens
治疗性抗体结构及其抗原的预测
- 批准号:
7279806 - 财政年份:2006
- 资助金额:
$ 29.39万 - 项目类别:
相似海外基金
Development study on the implanted antigen-antibody reaction sensor for bird
禽类植入式抗原抗体反应传感器的研制
- 批准号:
26630165 - 财政年份:2014
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Investigation for Antigen-Antibody Reaction on Solid Surface Using Total X-ray Reflection
利用全 X 射线反射研究固体表面上的抗原抗体反应
- 批准号:
19760006 - 财政年份:2007
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Influence of enhanced antigenicity of renal vascular endothelium induced ischemia/reperfusion injury on the antigen antibody reaction in organ transplantation and the study of protective strategy for enhancedantigenicity
肾血管内皮抗原性增强所致缺血/再灌注损伤对器官移植抗原抗体反应的影响及增强抗原性保护策略的研究
- 批准号:
15591668 - 财政年份:2003
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Selective bacteria detection using dielectrophoretic impedance measurement combined with antigen-antibody reaction
介电泳阻抗测量结合抗原抗体反应进行选择性细菌检测
- 批准号:
14550421 - 财政年份:2002
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Signal Transduction Induced by Desmosomal Cadherin Antigen-Antibody Reaction in Bullous Formation in Pemphigus
天疱疮大疱形成过程中桥粒钙粘蛋白抗原抗体反应诱导的信号转导
- 批准号:
07670938 - 财政年份:1995
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DEVELOPMENT OF THE INTRAOPERATIVE ESTIMATION OF THE PROXIMAL NERVE STUMP USING ANTIGEN-ANTIBODY REACTION ON THE ARTIFICIAL MEMBRANE
利用人工膜上抗原抗体反应进行近端神经残端术中估计的研究进展
- 批准号:
02670648 - 财政年份:1990
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Fluorescence Polarization and the Antigen-Antibody Reaction
荧光偏振和抗原抗体反应
- 批准号:
66B4288 - 财政年份:1966
- 资助金额:
$ 29.39万 - 项目类别: